← Analysis page  ·  Pieter Slegers hub  ·  Research hub

Actionable insights — ETF Portfolio Update August 2026

How to turn a word like "quality" into three computable inputs, how to read a fund's holdings against its own label, and what a paired US/non-US portfolio can teach you that a single one cannot.
2026-AUG-20 · Compounding Quality (Substack, paid post) · guest-authored by TJ Terwilliger · read ↗ · full analysis · transcript
How to read this page: the letter's own methods are in insights 1–3; insights 4–6 are diagnostic reading skills the issue rewards rather than teaches — the holdings-versus-label check, the natural experiment sitting inside a paired portfolio, and the missing-position audit. Written post, so no timestamps.

1. Turn a soft factor into the smallest set of computable inputs, and defend each one with its own evidence

The repeatable method
  1. Write down what you mean by the factor in words first (here: reinvests at high rates, survives, earns real cash).
  2. Assign each clause exactly one measurable input — return on equity, financial leverage, accruals ratio.
  3. Produce a separate piece of evidence that the input actually predicts returns, and read the shape of that evidence, not just its direction.
  4. Combine into a single score, then cut to a fixed count rather than a threshold, so the screen always returns a workable list.
  5. Decide the weighting rule separately from the selection rule — here score × market cap.
Here: SPHQ reduced to four steps: S&P 500 → score on three inputs → keep the top 100 → weight by quality score and market cap. Each input carries its own chart — MSCI on ROE quintiles, MSCI on leverage, AQR on negative-cash-flow companies — and the leverage evidence is explicitly asymmetric: "having little debt doesn't necessarily boost your returns. But having too much debt can seriously hurt them."
Watch for

2. Start portfolio design from the return distribution, not from the average

The repeatable method
  1. Look up the median outcome alongside the mean for whatever population you are about to buy.
  2. If the two diverge violently, treat the average as a description of a few names rather than of the population.
  3. Ask what a cap-weighted index actually buys under that distribution: everything, including the majority that loses money.
  4. Decide whether your response is to concentrate (own fewer, better) or to accept the average (own it all) — and be explicit that this is the choice being made.
Here: Bessembinder, quoted directly — "the average cumulative return was +22,840%. The median cumulative return was −7.41%" — over nearly a century, followed by the inference: "you get the highly profitable compounders, but you're also buying the companies destroying capital. As Quality Investors, we only want the best of the best."
Watch for

3. Run the same policy twice, in two wrappers, and use the pair as a natural experiment

The repeatable method
  1. Where a regulatory split forces two implementations of one strategy, map every position to its counterpart explicitly.
  2. Chart the pairs side by side on the same axis, so a difference in outcome is visible rather than buried in two separate reports.
  3. When a pair diverges materially, diagnose it: is it currency, index construction, geographic scope, or fee?
  4. Write the diagnosis down. A gap left unexplained becomes an unexamined bet.
Here: "If you live in the US, you can't buy non-US ETFs. If you live outside the US, you can't buy US ETFs" — hence two books. The paired chart shows the multifactor sleeve at roughly +62% (non-American) against +28.5% (American) and the wide-moat sleeve inverted, roughly +21% (GOAT.AS) against +34% (MOAT). The gaps are shown and then dismissed in one line: "over time, I expect both portfolios to generate similar returns."
Watch for

4. Read a rules-based fund by its holdings, not by its name

The repeatable method
  1. Pull the top ten and the sector split before accepting the label on the tin.
  2. Ask which businesses the screen's inputs would mechanically favour right now, given where each industry sits in its own cycle.
  3. Flag any holding whose high score depends on peak-cycle earnings — a trailing-ROE screen buys cyclicals at their best moment by construction.
  4. Cross-check the fund's largest positions against views you already hold on those same names elsewhere in your book.
  5. Size the position for the holdings you actually get, not for the factor you meant to buy.
Here: SPHQ is 42.5% Information Technology, led by Lam Research at 5.51% with Sandisk at 4.17% — semicap and memory. The same archive refused the memory complex a month earlier on the grounds that "these companies don't have any pricing power" and that margins already exceeded the 2018 peak. The quality screen and the house stock-picking view are, on this evidence, buying and refusing the same cycle.
Watch for

5. Audit each monthly letter for what has silently disappeared

The repeatable method
  1. Keep a running list of every position and every "of the month" pick as it is published.
  2. On each new issue, diff the current holdings chart against your list before reading the prose.
  3. Any name that vanished without a sell note is the highest-value question in the issue.
  4. Ask for the exit price and reason; absent that, treat the strategy's published record as incomplete.
Here: VFLO was the July ETF of the Month, written up in full and bought. It appears in none of the August weight or performance charts, and the disappearance is not mentioned anywhere in the issue.
Watch for

6. Compare the weighting order against the performance order every month

The repeatable method
  1. List the positions twice: once by weight, once by return.
  2. Where the two orders disagree sharply, ask whether the weighting expresses conviction, inertia, or a deliberate contrarian tilt.
  3. Check whether new money follows conviction or follows performance — adding to a winner and adding to a laggard are different policies and should be conscious.
  4. Re-read the sleeves the strategy claims to run against the weights actually deployed.
Here: the American book's largest holding is the small-cap sleeve at 23.1% but only fifth of seven on return (~24%); the best performer, EM multifactor at ~42%, is second-largest at 15.9%; the two min-vol sleeves are last in both books. The month's money goes to MOAT/GOAT.AS, already at 15% each — an add to a mid-table performer, with the justification given in a single sentence and no valuation attached.
Watch for

Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.